Vaxxas unveils positive clinical trial results for needle-free COVID-19 vaccine
Australia biotechnology company Vaxxas said it achieved positive interim results from a Phase I human clinical trial with the first needle-free COVID-19 vaccine candidate.Â
DroneShield to invest $13M in new Adelaide R&D facility
DroneShield Limited has announced it will invest $13 million over three years to establish a new research and development (R&D) facility in Adelaide, South Australia, as part of the company’s continued global expansion in counter-drone and electronic warfare (EW) technology.
QMI Solutions invites you to their Webinar: 3D printing technology / additive manufacturing can...
Additive manufacturing, also known as 3D printing, has been attracting a lot of attention both in Australia and globally, in terms of research activity...
Sparc on track for initial commercial production with ecosparc commission
Sparc Technologies has commissioned its graphene additive product, ecosparc, at its commercial production facility in Adelaide, South Australia.
Stratasys accepts entries for the 2017 Extreme Redesign 3D Printing Challenge
Stratasys has officially launched the 13th Annual Extreme Redesign 3D Printing Challenge with a formal call for entries.
According to the 3D printing giant, this...
EMVision expands product suite with 2nd gen helmet scanner prototype
Australian medical device company EMVision Medical Devices Limited announced the successful assembly of an advanced 28-antenna prototype for its 2nd Gen ultra-lightweight helmet scanner.
$1.1m commercialisation grant for 3D printing pen that corrects eye injuries
A team of scientists from the University of Sydney's Save Sight Institute have developed a BioPen that uses special ink to 'colour in' and treat...
Macquarie University engineers develop technology to boost solar panel recycling
A team of engineers from Macquarie University have developed a new microwave technology that would improve the fabrication of solar panel cells, making them easier to recycle.Â
EMVision activates stage two trial for portable brain scanner
ASX-listed EMVision Medical Devices (EMV) has moved forward to stage two of the multi-site trial for its first-generation portable brain scanner.
Panasonic unveils PH3 hydrogen fuel cell for Australian market
Panasonic is set to introduce commercial sales of Hydrogen Fuel Cells to the Australian market starting October 2024, acknowledging the burgeoning green hydrogen industry's growth in the country.


























